Company intelligence / Profile preview

Tuscaloosa Research and Education Advancement Corporation

Tuscaloosa, Alabama, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

TREAC supports and administers clinical research (phases unspecified) primarily focused on mental health and neurological disorders in Veterans, with multiple ongoing interventional and observational studies conducted in partnership with the VA and academic collaborators.[1][2]

Therapeutic areas: NeurologyPsychiatryOther
Modalities: Small moleculeBehavioral therapyDeviceNon-pharmacological therapyPeptides
Industry: Academic Hospital/University/Research

Partnerships

Tuscaloosa VA Medical CenterUniversity of AlabamaUS Department of DefenseNIH/NIA/NIMHPharmaceutical industry sponsors

Beyond the preview

Go deeper on Tuscaloosa Research and Education Advancement Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tuscaloosa Research and Education Advancement Corporation.

Explore the full profile